<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>20(1)</volume><submitter>Roseborough AD</submitter><funding>Natural Sciences and Engineering Research Council of Canada</funding><funding>Weston Brain Institute</funding><funding>Zywie Bio LLC</funding><funding>Canadian Consortium for Neurodegeneration in Aging</funding><funding>Canadian Foundation for Innovation</funding><funding>Canadian Institutes of Health Research</funding><pubmed_abstract>Chronic microglia activation post-stroke is associated with worse neurological and cognitive outcomes. However, measurement of microglia activation in vivo is currently limited. Plasma derived extracellular vesicles (EVs) are cell-specific indicators that may allow for non-invasive measurement of microglia phenotype. The aim of this study was to identify activation-state specific microglia EVs (MEVs) in vitro followed by validation in an experimental stroke model. Following pro-inflammatory activation, MEVs contain the microglia protein TMEM119 alongside increased expression of the Toll-like receptor 4 co-receptor CD14. Immunoprecipitation followed by fluorescent nanoparticle tracking analysis (ONI Nanoimager) was used to confirm the isolation of TMEM119&lt;sup>+&lt;/sup>/CD14&lt;sup>+&lt;/sup> EVs from rat plasma. Electron microscopy confirmed that TMEM119 and CD14 localize to the MEV membrane. To model ischemia, plasma was collected from 3-month wildtype Fischer344 rats prior to, 7 and 28 days after endothelin-1 or saline injection into the dorsal right striatum. Fluorescently labelled MEVs were directly measured in the plasma using nanoflow cytometry (Apogee A60 Microplus). We report a significant increase in circulating TMEM119&lt;sup>+&lt;/sup>/CD14&lt;sup>+&lt;/sup> EVs 28-days post-stroke in comparison to baseline levels and saline-injected rats, which correlated weakly with stroke volume. TMEM119&lt;sup>+&lt;/sup>/MHC-II&lt;sup>+&lt;/sup> EVs were also increased post-stroke in comparison to baseline and saline-injected animals. This study is the first to describe an EV biomarker of activated microglia detected directly in plasma following stroke and represents a future tool for the measurement of microglia activity in vivo.</pubmed_abstract><journal>Journal of neuroinflammation</journal><pagination>20</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9890769</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Plasma derived extracellular vesicle biomarkers of microglia activation in an experimental stroke model.</pubmed_title><pmcid>PMC9890769</pmcid><pubmed_authors>Roseborough AD</pubmed_authors><pubmed_authors>Zhao L</pubmed_authors><pubmed_authors>Whitehead SN</pubmed_authors><pubmed_authors>Khazaee R</pubmed_authors><pubmed_authors>Zhu Y</pubmed_authors><pubmed_authors>Pasternak SH</pubmed_authors><pubmed_authors>Myers SJ</pubmed_authors><pubmed_authors>Elahi FM</pubmed_authors><pubmed_authors>Iorio E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Plasma derived extracellular vesicle biomarkers of microglia activation in an experimental stroke model.</name><description>Chronic microglia activation post-stroke is associated with worse neurological and cognitive outcomes. However, measurement of microglia activation in vivo is currently limited. Plasma derived extracellular vesicles (EVs) are cell-specific indicators that may allow for non-invasive measurement of microglia phenotype. The aim of this study was to identify activation-state specific microglia EVs (MEVs) in vitro followed by validation in an experimental stroke model. Following pro-inflammatory activation, MEVs contain the microglia protein TMEM119 alongside increased expression of the Toll-like receptor 4 co-receptor CD14. Immunoprecipitation followed by fluorescent nanoparticle tracking analysis (ONI Nanoimager) was used to confirm the isolation of TMEM119&lt;sup>+&lt;/sup>/CD14&lt;sup>+&lt;/sup> EVs from rat plasma. Electron microscopy confirmed that TMEM119 and CD14 localize to the MEV membrane. To model ischemia, plasma was collected from 3-month wildtype Fischer344 rats prior to, 7 and 28 days after endothelin-1 or saline injection into the dorsal right striatum. Fluorescently labelled MEVs were directly measured in the plasma using nanoflow cytometry (Apogee A60 Microplus). We report a significant increase in circulating TMEM119&lt;sup>+&lt;/sup>/CD14&lt;sup>+&lt;/sup> EVs 28-days post-stroke in comparison to baseline levels and saline-injected rats, which correlated weakly with stroke volume. TMEM119&lt;sup>+&lt;/sup>/MHC-II&lt;sup>+&lt;/sup> EVs were also increased post-stroke in comparison to baseline and saline-injected animals. This study is the first to describe an EV biomarker of activated microglia detected directly in plasma following stroke and represents a future tool for the measurement of microglia activity in vivo.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2026-07-09T12:23:36.308Z</modification><creation>2025-04-05T20:52:32.455Z</creation></dates><accession>S-EPMC9890769</accession><cross_references><pubmed>36721258</pubmed><doi>10.1186/s12974-023-02708-x</doi></cross_references></HashMap>